The Diagnostic Imaging CT modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of CT across the healthcare continuum, from various cancer screenings, such as lung and colon, to cardiothoracic imaging, to appendicitis, and more.
November 20th 2024
While a large retrospective study found that interstitial lung abnormalities (ILAs) were evident on 1.7 percent of computed tomography (CT) scans, researchers found that 43.9 percent of ILAs, including fibrotic ILAs, were not reported.
19th Annual New York Lung Cancers Symposium®
November 16, 2024
Register Now!
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Medical Crossfire®: How Do the Experts Select and Sequence Therapies to Optimize Patient Outcomes and Quality of Life in Advanced Prostate Cancer?
View More
Lung Cancer Tumor Board®: Enhancing Multidisciplinary Communication to Optimize Immunotherapy in Stage I-III NSCLC
View More
Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings
View More
School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio
View More
Annual Hawaii Cancer Conference
January 25-26, 2025
Register Now!
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
18th Annual New York GU Cancers Congress™
March 28-29, 2025
Register Now!
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
Waste not, want not: Getting the most from imaging procedures
March 19th 2010The amount of data obtained in a single MR or CT scan is mind-boggling. At least some of the data radiologists throw away could save patients money while reducing their exposure to radiation and risk of complications from invasive procedures.
Singapore Radiological Society holds its 19th Annual Scientific Meeting
March 15th 2010The 19th Annual Scientific Meeting of the Singapore Radiological Society was jointly organized with the College of Radiologists, Singapore, from Feb. 25 through 28. I have attended this meeting the past three years as it gives me ample opportunity to interact with my colleagues and feel the pulse of radiology in and around the region. Each year, the focus is on a hot topic, and this year’s topic was nuclear medicine and molecular imaging.
Effective use of abdominal CT can save lives in emergency setting
March 10th 2010It is widely accepted that reducing time from admission to definitive care saves lives, but usually imaging is one of the major sources of delays. This means radiologists play a vital role in prioritizing patients and selecting the correct modality.
Vendors look to mathematical solutions to minimize CT dose, improve safety
March 5th 2010Radiology is a medical specialty created by a fertile marriage between biology and physics. But it is an entirely different academic discipline that is the focus of the research by major vendors of CT technology on show this year at the ECR’s technical exhibition. Their studies have centered on the subject that the illustrious 19th century German scientist Carl Friedrich Gauss called “the queen of sciences”: mathematics.
Will CT overtake nuclear medicine in myocardial perfusion?
February 25th 2010It’s not enough that sidelined nuclear reactors are restricting the supply of technetium for cardiac SPECT. Or that reimbursements for SPECT procedures are falling. Now the besieged modality has to contend with a challenge from CT.
Cedars-Sinai accidents stir interest in scanner security
January 25th 2010In the aftermath of CT-related radiation accidents at the prestigious Cedars-Sinai Medical Center in Los Angeles, the FDA, healthcare providers, and manufacturers are taking action to avoid suffering through similar situations themselves.
Multigland parathyroidism reduces accuracy of lesion detection
December 4th 2009Standard nuclear scintigraphy of parathyroid cancer produces enough false positives for patients with multigland disease to lead researchers to recommend rapid intraoperative parathyroid hormone assay along with preoperative technetium-99m sestamibi imaging to assure that all lesions have been removed.
Siemens IT platform promises boost in MR, CT productivity
December 1st 2009Siemens unveiled a new information technology at RSNA 2009: software that promises to do the tedious and time-consuming tasks involved in reading MR and CT exams. The new product, a work-in-progress pending FDA clearance, is an outgrowth of the syngo platform that Siemens has used for years to provide consistency in data processing among its modalities.
CTA predicts healing of bone fractures
November 29th 2009Findings of a study released Sunday at the 2009 RSNA meeting by researchers in Boston suggest CT angiography could help radiologists identify the factors that keep some types of lower extremity fractures from healing faster and better than other, similar lesions.
CT colonography tops colonoscopy for mapping colon cancer segmentation
November 20th 2009CT colonography can pinpoint cancerous colorectal segments more accurately than colonoscopy, according to Italian investigators. They say virtual, not optical, colonoscopy should be the gold standard for the preoperative staging of colorectal cancer.
Cardiac scientific sessions examine outcomes, contrast media use
November 17th 2009Cardiac imaging researchers are expanding the scope of topics considered at the 2009 RSNA meeting to include iodinated contrast media administration as a safety issue and clinical outcomes studies that weigh the relative merits of cost and clinical efficacy.
CT colonography papers flood the gates at McCormick Place
November 17th 2009Rather than retreating after the hard blow handed them by the Centers for Medicare and Medicaid Services, which refused to grant reimbursement for the application in May, CT colonography researchers will arrive at the 2009 RSNA meeting with more of what CMS wants: hard data.
Team studies 3D filtering for MR, CT
November 13th 2009OEM-software supplier ContextVision, its sister provider of end user products SharpView, and the Massachusetts General Hospital are investigating advanced 3D image filtering as a means to boost productivity and improve image quality for MRI, as well as cut dose in CT.
Imagers question New England Journal CT dose critique
November 11th 2009Imaging advocates, including the American College of Cardiology, cautioned against giving too much credence to a study in the New England Journal of Medicine concluding that adults are exposed to excessive doses of radiation from medical imaging procedures that are not supported by the clinical data.